RAYENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,550 KRW | +1.06% |
|
+1.06% | -8.56% |
| Mar. 18 | Rayence Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Rayence Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2023 | CI |
| Sales 2024 * | 150B 109M | Sales 2025 * | 163B 119M | Capitalization | 135B 98.22M |
|---|---|---|---|---|---|
| Net income 2024 * | 21B 15.33M | Net income 2025 * | 24B 17.52M | EV / Sales 2024 * | -0.01 x |
| Net cash position 2024 * | 135B 98.84M | Net cash position 2025 * | 152B 111M | EV / Sales 2025 * | -0.11 x |
| P/E ratio 2024 * |
6.5
x | P/E ratio 2025 * |
5.8
x | Employees | 222 |
| Yield 2024 * |
3.51% | Yield 2025 * |
3.51% | Free-Float | 29.83% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.06% | ||
| 1 week | +1.06% | ||
| Current month | -4.68% | ||
| 1 month | -5.11% | ||
| 3 months | -6.25% | ||
| 6 months | -6.25% | ||
| Current year | -8.56% |
1 week
8 320.00
8 610.00
1 month
8 030.009 140.00
Current year
8 030.009 430.00
1 year
8 030.0012 350.00
3 years
8 030.0017 350.00
5 years
7 140.0017 350.00
10 years
7 140.0024 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jae-Jeong Seo
CEO | Chief Executive Officer | 50 | - |
Tae-Wu Kim
BRD | Director/Board Member | 51 | - |
Chang-Joon Ro
BRD | Director/Board Member | 65 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang-Joon Ro
BRD | Director/Board Member | 65 | - |
Tae-Wu Kim
BRD | Director/Board Member | 51 | - |
Jae-Jeong Seo
CEO | Chief Executive Officer | 50 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 8,550 | +1.06% | 5,372 |
| 24-04-22 | 8,460 | +0.24% | 3,837 |
| 24-04-19 | 8,440 | -0.12% | 8,168 |
| 24-04-18 | 8,450 | +0.36% | 7,504 |
| 24-04-17 | 8,420 | -0.47% | 9,738 |
End-of-day quote Korea S.E., April 22, 2024
More quotes
Rayence Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical and veterinary X-ray detector products. Its products include thin film transistor (TFT) detectors and complementary-metal-oxide-semiconductor (CMOS) detectors. The products' brand name consists of 1012WCA, 17SCC/SGC, 1215CF, 1501CF and 0712CF. The Company also manufactures intra oral (I/O) sensors under the brand name of Ez1.0, Ez1.5, and mammography (mammo) machines under the brand 1724CM, 2434CM. The Company distributes its products to domestic and overseas markets.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8,550
KRW
Average target price
13,000
KRW
Spread / Average Target
+52.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.56% | 98.02M | |
| -7.72% | 14.38B | |
| -40.07% | 2.74B | |
| -16.70% | 2.34B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +46.15% | 538M | |
| +80.77% | 474M | |
| 0.00% | 215M | |
| +0.37% | 181M |
- Stock Market
- Equities
- A228850 Stock
